MedDataX Logo

Clinicopathological Features of Renal Cell Carcinoma in Young Patients

NCT ID: NCT06730997

Last Updated: 2024-12-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-01

Study Completion Date

2027-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Analysis of Clinicopathologic Characters of Renal Cell Carcinoma in Young Patients and their influence on the survival outcomes

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Worldwide, RCC accounts for 2-3% of All adult malignancies and the 8th most commonly diagnosed primary cancer among all adults.

Representing 3rd place among urinary system tumors. Most of RCC occurs in old age while about 7% occurs in younger adults below 40 years.

Recently the published data about the tumor Clinco-pathological features, treatment response and outcomes were different in young adults than older patients, where some data showed favorable features and survivals, while other showed negative ones.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Clinicopathologic Characters of Renal Cell Carcinoma in Young Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \< 40 years

* Patients proven to have RCC
* Patients eligible to receive treatment

Exclusion Criteria

* Second malignancy.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dina Gamal Abdelaziz Farrag

physion

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dina Gamal Abdelaziz

Role: CONTACT

Phone: 01147625820

Email: [email protected]

References

Explore related publications, articles, or registry entries linked to this study.

Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol. 2006 Dec;176(6 Pt 1):2353-8. doi: 10.1016/j.juro.2006.07.130.

Reference Type BACKGROUND
PMID: 17085101 (View on PubMed)

Suh JH, Oak T, Ro JY, Truong LD, Ayala AG, Shen SS. Clinicopathologic features of renal cell carcinoma in young adults: a comparison study with renal cell carcinoma in older patients. Int J Clin Exp Pathol. 2009;2(5):489-93. Epub 2009 Jan 30.

Reference Type BACKGROUND
PMID: 19294008 (View on PubMed)

Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol. 2016 Jul;70(1):93-105. doi: 10.1016/j.eururo.2016.02.029. Epub 2016 Feb 28.

Reference Type BACKGROUND
PMID: 26935559 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Renal cell carcinoma

Identifier Type: -

Identifier Source: org_study_id